ELOVL5 and colon adenocarcinoma: The Cancer Genome Atlas (TCGA) survival data that linked ELOVL5 expression level with overall survival of patients with colon adenocarcinoma revealed better survival rates for patients with low expression of ELOVL5 (<10th percentile) compared to patients with high expression of ELOVL5 (>50th percentile) (Figure 3(B)).